Landmark Bio: Valuation, Funding & Investors
Landmark Bio is a biotechnology company developing scalable manufacturing technologies for extracellular vesicles (EVs). The company focuses on building efficient continuous manufacturing platforms to support advanced therapies, including viral vectors and cell therapies.
Leadership & Board
- Current Number of Employees
- 34
- Current LinkedIn Followers
- 7,191
Latest Estimated Valuation
- Total Amount Raised
- $18M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $18M
- Latest Funding Round
- Investment
Employee Trend
Landmark Bio had 34 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
34Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Landmark Bio had 7,191 followers as of October 26, 2026. The number of followers increased by 50 (0.70%) week-over-week.
7,191Latest Followers Count
50(0.70%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Apr 16, 2026 | Investment | $18.30M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ARPA-H | Investment |
Similar Companies
A snapshot of private companies similar to Landmark Bio, helping you discover and navigate related company profiles.
Related News and Analysis
